ISR — ISR Immune System Regulation Holding AB (publ) Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Brief: Iconovo Signs Agreement With ISR For Development Of Inhaled COVID-19 Vaccine
Brief: ISR Gets Sek 22.2 Million Through Excercise Of Warrants
Brief: ISR Immune System Regulation Gets Research Grant From Vinnova
Brief: ISR: Start Of Drug Study For HIV Patients Approved In Germany
Brief: ISR: Promising Results For ISR's Development Of COVID-19 Vaccine
Brief: ISR Holdings Enters Collaboration With Beijing Kawin Technology Share-Holding
Brief: ISR Decides On Directed New Issue Of Up To 1 Mln Shares
Brief: ISR Carries Out Rights Issue Of About SEK 71.7 Mln
Brief: ISR Immune System Regulation Holding: Rights Issue Heavily Oversubscribed
Brief: ISR Carries Out Fully Guaranteed Rights Issue Of About SEK 71.7 Million
Brief: ISR Immune System Regulation Holding: Loan Of SEK 20 Million Extended
Brief: ISR H2 Operating Loss Widens To SEK 13.1 Million
Brief: ISR HBV Investigates Program For Coronavirus
Brief: ISR Initiates Collaboration With Chinese InnoStar For The Treatment Of Hepatitis B
Brief: ISR Immune System Regulation Holding H1 Net Loss Widens To SEK 15.8 Mln
Brief: ISR Plans New Study With HIV Patients
Brief: Isr Immune System Regulation Holding AB (Publ) Creates New Unit Isr Hbv AB
Brief: ISR Holding Raises SEK 34.2 Mln In Issues
Brief: ISR To Carry Out Private Placement And Rights Issue